Epigenetic studies may also illuminate some other unclear issues in the regulation of D2 dopamine receptor expression such as the mismatch between D2 mRNA level and receptor density in the brains of experimental animals 14 as well as the potential discrepancy between normal D2 mRNA level 15 and increased density of D2-like receptors 16 in the brain of schizophrenia patients. There is increasing evidence that epigenetic factors regulate not only the amount of mRNA molecules of a specific gene but also the nuclear location and the time of expression during a specific period in the cell cycle. 17 mRNA, although produced at an appropriate level but at a wrong time and/or at an aberrant location in the nucleus, may lead to a different translational efficiency and may have a significant effect on cell biology.
In conclusion, a combined epigenetic and DNA sequence variation-based representation of DRD2, such as epigenotypes, epialleles and epihaplotypes, may lead to new developments in understanding the role of genetic and epigenetic factors on D2 receptor density, affinity and other features of functioning of the dopaminergic system in normal and affected brain. I suggest molecular heterosis as a much better explanation for the differences in the two studies and when viewed in this fashion both studies support a role of the DRD2 gene in the regulation of striatal dopamine D 2 receptor density. Heterosis refers to a situation in which a given trait is significantly greater (or lesser) in heterozygotes than in either homozygote. One of the best examples is the significantly greater vigor and yield in hybrid corn than in either parental strain. Molecular heterosis 4 refers to situtations where a trait is significantly greater (or lesser) in individuals heterozygous at a specific gene marker than those homozygous for either allele. We have observed molecular heterosis at the TaqI A1/A2 polymorphism of the DRD2 gene for a wide range of behavioral variables. An example of this for the inattention subscore of Attention Deficit Hyperactivity Disorder (ADHD) 4 is shown in Figure 1a . The quantitative inattention score was highest (positive heterosis) for 12 heterozygotes, lowest for 11 homozygotes, and intermediate for 22 homozygotes. I have plotted the score with an inverted scale for easier comparison with the following other results.
A Petronis
Biochemical support for molecular heterosis at the TaqI polymorphism of the DRD2 gene was reported by Jö nsson et al. 5 These results are shown in Figure 1b . They observed a significant decrease in CSF HVA levels in 12 heterozygotes (negative heterosis) compared to 11 + 22 homozygotes. By contrast, there was no sig- nificant difference when compared on the basis of those carrying the 1 allele (11 + 12 genotype) vs those not carrying the 1 allele (22 genotype). This is because the higher levels for the smaller number of subjects with the 11 genotype meant that the mean HVA levels for those with the 11 + 12 genotypes were virtually identical to those with the 22 genotype. The results for behavior and HVA levels show that when molecular heterosis is involved it is critical to examine variables on the basis of genotype rather than alleles.
Noble et al examined the striatal B max and K d of the dopamine D 2 receptor 6 in the brain samples of their original sample of controls and alcoholics. This showed a significant decrease in B max across the three genotypes from 22 to 12 to 11. The results in the controls are shown in Figure 1c . While these results do not suggest heterosis when B max is used as the endpoint, there were only two 11 cases (shown as ˼'s). Thompson et al 7 reported a study of D 2 receptor binding in the caudate, putamen and nucleus accumbens of 44 subjects, measured by autoradiography with [ 3 H]-raclopride. They were also genotyped at the D 2 Taq A1 allele. These results are shown in Figure 1d . There was only one subject with the 11 geneotype (shown as ˼). She showed a level of D 2 binding that was comparable to the mean of the 12 subjects. There was a significant decrease in D 2 Figure 1f ). However, they did note that there were four A1/A1 homozygotes and they had the highest receptor-binding potential of any of the genotypes (284 ± 61 ml g
−1
). Removing these from the A1
+ group results in lowering the mean D 2 receptor-binding potential for the total 12 heterozygotes from 230 ml g −1 to 220.6 ml g −1 . These results, shown in Figure 1f , are compatible with negative molecular heterosis. Based on the suggestion of Hitzeman 3 that the results for controls would be more accurate than those for schizophrenics, I have estimated what the results might be for the controls only. I was able to do this because the authors of the Laruelle et al 2 study were kind enough to tell me that of the four 11 homozygotes, three were in the control group while one was in the schizophrenia group. Removing those three from the A1 + group resulted in a mean D 2 receptor-binding potential for the 12 heterozygotes of 201 ml g −1 and an average for the 11 homozygotes of 284 ml g . These results, shown in Figure 1g , are even more compatible with molecular heterosis compared to when the schizophrenia cases are included. In fact, the striking differences between the controls and schizophrenics suggest that perhaps schizophrenia is characterized by a lack of a heterosis effect at the DRD2 gene. To examine this, I have also plotted the results in the schizophrenia group by genotype assuming that the one remaining 11 schizophrenic homozygote had a receptor-binding potential of approximately of 283 ml g −1 . Figure 1h shows the results. These data suggest that molecular heterosis at the DRD2 locus appears not to occur in schizophrenia. If the lack of molecular heterosis at the DRD2 gene was due to the disease rather than an artifact due to prior neuroleptic exposure, it could be an important finding for schizophrenia. The potential relevance of molecular heterosis to the interpretation of the role of the DRD2 in alcoholism has been presented elsewhere. 4 Molecular heterosis is not rare. We have reviewed its presence at other gene loci including DRD1, DRD3, DRD4, ADR2AC, HTR2A, HTT, HLA, ␣-CAMKII, ESR, secretor, C3 complement, properdinB, ␤-globin, and haptoglobin genes (unpublished). Molecular heterosis is counter-intuitive since one would expect that if one allele is associated with a lower level of gene expression, it should be lower in homozygotes than in heterozygotes. For receptors, one explanation could be that the range of expression of the receptor on the surface of neurons is much greater in heterozygotes and over the period of time from conception to adolescence and adulthood that could lead to a greater range of resilience or responsiveness for different outcomes or phenotypes. The most reliable way to confirm or exclude the presence of molecular heterosis would be to accumulate more PET or SPECT data on the levels of the striatal D 2 receptor in 11 homozygotes.
If an absence of molecular heterosis at the DRD2 gene is characteristic of schizophrenia, and further studies verify such a difference between controls and schizophrenics, identifying the mechanism would be important. Lynch and Walsh 8 cited the important role of genetic background in heterosis, and the difference between controls and schizophrenics could be due to their different genetic backgrounds.
Based on the analyses presented here I propose that the differences between the Pohjalainen et al 1 and Laruelle et al 2 studies are due primarily to a failure to consider the effect of molecular heterosis. When heterosis is considered, the results suggest that the TaqI A1/A2 genotypes of the DRD2 gene do correlate with dopamine D 2 receptor density, and that schizophrenia may be characterized by a loss of this effect. The ability of the TaqI A polymorphism, located 3Ј to the DRD2 gene, to effect gene function may be because it is in linkage disequilibrium with a minisatellite polymorphism. 9 The studies of Paquette et al 10 have shown that the effect of minisatellite polymorphisms on gene function can occur over considerable distances.
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Evidence for an association between heroin dependence and a VNTR polymorphism at the serotonin transporter locus SIR -Substance abuse is a very complex disorder. Although it is commonly accepted that environmental influences are the primary factors leading to substance abuse and addiction, there is strong consensus for some genetic contribution to the etiopathology involved. For example, there is evidence that personality traits such as novelty seeking are inherited. 1 Association studies with candidate genes aim to dissect and identify important genetic factors contributing to such noveltyseeking behavior. As abnormalities in the dopami-
